San Diego-based ACADIA Pharmaceuticals Inc. has named Austin Kim as executive vice president, general counsel and secretary.
ACADIA specializes in the development and commercialization of medicines to treat central nervous system disorders.
The hiring of Austin Kim as GC comes just a few months after the U.S. Food and Drug Administration said it is re-evaluating ACADIA’s Nuplazid, the only drug approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.
July 20, 2018 at 12:30 PM
1 minute read
The original version of this story was published on Corporate Counsel
San Diego-based ACADIA Pharmaceuticals Inc. has named Austin Kim as executive vice president, general counsel and secretary.
ACADIA specializes in the development and commercialization of medicines to treat central nervous system disorders.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS